[1] EVANGELOU Z, ZARACHI A, DUMOLLARD J M, et al. Maxillary ameloblastoma: a review with clinical, histological and prognostic data of a rare tumor[J].In Vivo, 2020, 34(5):2249-2258.
[2] GORLIN R J, CHAUDHRY A P, PINDBORG J J. Odontogenic tumors. Classification, histopathology, and clinical behavior in man and domesticated animals[J].Cancer, 1961, 14:73-101.
[3] HEIKINHEIMO K, KURPPA K J, LAIHO A, et al. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor[J].J Dent Res, 2015, 94(1):101-111.
[4] ODUKOYA O, EFFIOM O A. Clinicopathological study of 100 Nigerian cases of ameloblastoma[J].Niger Postgrad Med J, 2008, 15(1):1-5.
[5] CARDOSO A, LAZOW S K, SOLOMON M P, et al. Metastatic ameloblastoma to the cervical lymph nodes: a case report and review of literature[J].J Oral Maxillofac Surg, 2009, 67(6):1163-1166.
[6] SARRADIN V, SIEGFRIED A, URO-COSTE E, et al. WHO classification of head and neck tumours 2017: main novelties and update of diagnostic methods[J].Bull Cancer,2018,105(6):596-602.
[7] ZWAHLEN R A, GRÄTZ K W. Maxillary ameloblastomas: a review of the literature and of a 15-year database[J].J Craniomaxillofac Surg, 2002, 30(5):273-279.
[8] HENDRA F N, VAN CANN E M, HELDER M N, et al. Global incidence and profile of ameloblastoma: a systematic review and meta-analysis[J].Oral Dis, 2020, 26(1):12-21.
[9] BI L, WEI D, HONG D, et al. A retrospective study of 158 cases on the risk factors for recurrence in ameloblastoma[J].Int J Med Sci, 2021, 18(14):3326-3332.
[10]CHEHAL A, LOBO R, NAIM A, et al. Ameloblastoma of the maxillary sinus treated with radiation therapy[J].Pan Afr Med J, 2017, 26:169.
[11]REICHART P A, PHILIPSEN H P, SONNER S. Ameloblastoma: biological profile of 3677 cases[J].Eur J Cancer B Oral Oncol, 1995, 31B(2):86-99.
[12]FERREIRA T S H, PIMENTEL I M F, DE ALBUQUERQUE L A F, et al. Pure endoscopic transsphenoidal treatment of skull base ameloblastoma with intracranial extension: case report and literature review[J].Surg Neurol Int, 2020, 11:228.
[13]FIEDLER L S, WUNSCH A. Ameloblastoma of the maxillary sinus: conservative surgical management considering high recurrence risk potential[J].BMJ Case Rep, 2021, 14(5):e241487.
[14]PITAK-ARNNOP P, SUBBALEKHA K, SIRINTAWAT N, et al. A retrospective cohort study on predictors associated with skull base invasion of maxillary ameloblastomas[J].J Stomatol Oral Maxillofac Surg, 2022, 123(5):e439-e447.
[15]SWEENEY R T, MCCLARY A C, MYERS B R, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas[J].Nat Genet, 2014, 46(7):722-725.
[16]SHAHIDI S, BRONOOSH P, DANESHBOD Y. Follicular ameloblastoma presenting as a sinonasal tumor[J].Iran Red Crescent Med J, 2012, 14(2):113-116.
[17]SEHDEV M K, HUVOS A G, STRONG E W, et al. Proceedings: ameloblastoma of maxilla and mandible[J].Cancer, 1974, 33(2):324-333.
[18]GHANDHI D, AYOUB A F, ANTHONY POGREL M, et al. Ameloblastoma: a surgeon’s dilemma[J].J Oral Maxillofac Surg, 2006, 64(7):1010-1014.
[19]ROSENSTEIN T, POGREL M A, SMITH R A, et al. Cystic ameloblastoma-behavior and treatment of 21 cases[J].J Oral Maxillofac Surg, 2001, 59(11):1311-1318.
[20]CARLSON E R, MARX R E. The ameloblastoma: primary, curative surgical management[J].J Oral Maxillofac Surg, 2006, 64(3):484-494.
[21]YANG R, LIU Z, PENG C, et al. Maxillary ameloblastoma: Factors associated with risk of recurrence[J].Head Neck, 2017, 39(5):996-1000.
[22]HENDRA F N, NATSIR KALLA D S, VAN CANN E M, et al. Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis[J].Oral Dis, 2019, 25(7):1683-1696.
[23]KALWAGADDA S, KUMAR B, NAIR S C, et al. Management of ameloblastoma with free tissue flap in comparison with other reconstructive options available[J].J Maxillofac Oral Surg, 2020, 19(2):283-288.
[24]ELMRINI S, RAITEB M, RAZEM B, et al. Ameloblastoma giant: diagnosis, treatment and reconstruction: a case report[J].Ann Med Surg: Lond, 2021, 68:102589. |
